BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 4970016)

  • 1. The prevention of Rh-haemolytic disease.
    Clarke CA
    Sci Basis Med Annu Rev; 1968; ():168-85. PubMed ID: 4970016
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations concerning the prevention of rhesus immunization in the Netherlands].
    de Bruijne JI; van der Weerdt CM; Stallman HF; Hartgerink MJ; borst-Eilers E; Dudok de Wit C
    Ned Tijdschr Geneeskd; 1968 Dec; 112(52):2367-70. PubMed ID: 4974071
    [No Abstract]   [Full Text] [Related]  

  • 3. [Haemolytic disease of the newborn (fetus) (author's transl)].
    Fischer K; Poschmann A
    Immun Infekt; 1976 Dec; 4(6):249-60. PubMed ID: 828142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The RH-conflict and its position in present-day obstetrics].
    Möbius W; Krause W; Kadner J
    Zentralbl Gynakol; 1973 Sep; 95(38):1329-36. PubMed ID: 4203838
    [No Abstract]   [Full Text] [Related]  

  • 5. [The prevention of rhesus immunization with anti-rhesus (D) immunoglobulin. Report of a clinical study carried out in Dutch hospitals].
    Dudok De Wit C; Borst-Eilers E; van der Weerdt CM; Kloosterman GJ
    Ned Tijdschr Geneeskd; 1968 Dec; 112(52):2345-51. PubMed ID: 4974070
    [No Abstract]   [Full Text] [Related]  

  • 6. [Actual possibilities of prevention of serologic incompatibility].
    Breborowicz H; Gerwelowa H; Krawczyńska Z; Baraniecka K; Gruszczyńska J; Karowa L
    Pol Tyg Lek; 1968 Sep; 23(35):1305-7. PubMed ID: 4972438
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy and prevention of hemolytic disease of the newborn caused by the Rh factor].
    Kogoj-Bakic V
    Lijec Vjesn; 1970 Nov; 92(11):1323-31. PubMed ID: 4332439
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of Rh haemolytic disease.
    Clarke CA
    Nurs Mirror Midwives J; 1974 Oct; 139(17):57-9. PubMed ID: 4139694
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rh-antibodies in women receiving preventive treatment against Rh-immunization. Experiences after 2 years preventive program].
    Orjasaeter H
    Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2412-4. PubMed ID: 4120943
    [No Abstract]   [Full Text] [Related]  

  • 10. [Practical experiences with the anti-D-IgG prevention of Rh-immunization].
    Bergmann H; Leinzinger E; Pazdernik I; Haider M
    Wien Med Wochenschr; 1969 Jan; 119(1):9-12. PubMed ID: 4975236
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of Rh-haemolytic disease--1969.
    Med J Aust; 1969 May; 1(20):1035-6. PubMed ID: 4182380
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary experiences with the prevention of Rh sensitization].
    Aeppli H; Nwebube G
    Gynaecologia; 1969; 168(6):481-3. PubMed ID: 4993890
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary experiences with ther prevention of Rh sensitization].
    Aeppli H; Nwebube G
    Gynaecologia; 1969; 168(6):481-3. PubMed ID: 4993202
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of Rh-immunization with the Rho(D)-immunoglobulin G (RhoGAM)].
    Robertson JG
    Med Welt; 1970 Nov; 46():1991-5. PubMed ID: 4997857
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of Rh sensitization by means of anti D application].
    Schneider J
    Bibl Haematol; 1969; 32():113-23. PubMed ID: 4980798
    [No Abstract]   [Full Text] [Related]  

  • 16. [Conditions of the prevention of neonatal hemolytic diseases resulting from Rh(D) incompatibility in Hungary].
    Simonovits I; Garancsy L; Böröcz I
    Orv Hetil; 1980 Apr; 121(15):875-8. PubMed ID: 6770319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of anti Rh immunization].
    Pinon F
    Sem Hop; 1969 Sep; 45(37):2328-33. PubMed ID: 4187740
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of hemolytic disease of the newborn using anti-rhesus (D) gamma globulin].
    Borst-Eilers E
    Maandschr Kindergeneeskd; 1969 Dec; 37(7):243-51. PubMed ID: 4188422
    [No Abstract]   [Full Text] [Related]  

  • 19. [Present status of the prevention of hemolytic disease of the newborn due to Rh factors incompatibility].
    de Sousa JS
    Rev Port Pediatr Pueric; 1969; 32(3):70-6. PubMed ID: 4185738
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlation between the presence of cytotoxic anti-HL-A antibodies in the clinical course of hemolytic disease of the newborn infant due to anti-Rh (D) or immune anti-A/B erythrocyte antibodies].
    Gligorović VN; Gligorović S; Susaković N; Lopicić L; Stolić I; Marković V; Matejić T
    Bilt Hematol Transfuz; 1976; 4(3):23-31. PubMed ID: 827283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.